Discontinuation report XARELTO
Report ID | 68808 |
Drug Identification Number | 02441535 |
Brand name | XARELTO |
Common or Proper name | rivaroxaban |
Company Name | BAYER INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | RIVAROXABAN RIVAROXABAN |
Strength(s) | 15MG 20MG |
Dosage form(s) | TABLET KIT |
Route of administration | ORAL |
Packaging size | 49 |
ATC code | B01AF |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2018-12-01 |
Actual discontinuation date | 2018-12-01 |
Remaining supply date | 2018-12-01 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2018-12-05 | French | Compare |
v2 | 2018-12-05 | English | Compare |
v1 | 2018-12-05 | English | Compare |
Showing 1 to 3 of 3